Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Yu Chang

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2022
Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/ValsartanPo-Lin Lin, Ying-Hsiang Lee, Lawrence Yu-Min Liu, et al.
Journal of Cardiology|April 16, 2019
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalationHung-Yu Chang, An-Ning Feng, Man-Cai Fong, et al.
Renal Failure|September 10, 2004
Diabetes mellitus, hyperhomocystinemia and atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective studyChil-Hsiung Lee, Hsueh-Wen Chang, I-Kuan Wang, et al.
ESC Heart Failure|July 30, 2021
The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patientsChia-Te Liao, Jin-Long Huang, Huai-Wen Liang, et al.
Journal of the Chinese Medical Association : JCMA|June 14, 2023
Iron deficiency in Taiwanese patients with heart failure and reduced ejection fractionHsiao-Ping Sung, Chien-Yi Hsu, Ying-Hsiang Lee, et al.
Renal Failure|May 15, 2007
Varicella-zoster infection with encephalopathy, pneumonia, and renal failure: a case reportFeng-Rong Chuang, Chih-Hsiung Lee, Chung-Hua Chuang, et al.
Journal of the Chinese Medical Association : JCMA|April 26, 2021
The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectivenessHuai-Wen Liang, Chia-Te Liao, Wen-Yu Lin, et al.
Acta Cardiologica Sinica|July 14, 2021
The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure MedicationsMan-Cai Fong, Hung-Yu Chang, Chun-Chieh Wang, et al.
ESC Heart Failure|January 7, 2021
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fractionYing-Hsiang Lee, Po-Lin Lin, Wei-Ru Chiou, et al.
Journal of the Chinese Medical Association : JCMA|September 15, 2021
Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF studyWen-Yu Lin, Fa-Po Chung, Chia-Te Liao, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Journal of Cardiovascular Pharmacology and Therapeutics|June 17, 2022
Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/ValsartanPo-Lin Lin, Ying-Hsiang Lee, Lawrence Yu-Min Liu, et al.
Journal of Cardiology|April 16, 2019
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalationHung-Yu Chang, An-Ning Feng, Man-Cai Fong, et al.
Renal Failure|September 10, 2004
Diabetes mellitus, hyperhomocystinemia and atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective studyChil-Hsiung Lee, Hsueh-Wen Chang, I-Kuan Wang, et al.
ESC Heart Failure|July 30, 2021
The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patientsChia-Te Liao, Jin-Long Huang, Huai-Wen Liang, et al.
Journal of the Chinese Medical Association : JCMA|June 14, 2023
Iron deficiency in Taiwanese patients with heart failure and reduced ejection fractionHsiao-Ping Sung, Chien-Yi Hsu, Ying-Hsiang Lee, et al.
Renal Failure|May 15, 2007
Varicella-zoster infection with encephalopathy, pneumonia, and renal failure: a case reportFeng-Rong Chuang, Chih-Hsiung Lee, Chung-Hua Chuang, et al.
Journal of the Chinese Medical Association : JCMA|April 26, 2021
The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectivenessHuai-Wen Liang, Chia-Te Liao, Wen-Yu Lin, et al.
Acta Cardiologica Sinica|July 14, 2021
The Characteristics and Outcomes of Patients with Heart Failure and Reduced Ejection Fraction: The Eligibility of Novel Heart Failure MedicationsMan-Cai Fong, Hung-Yu Chang, Chun-Chieh Wang, et al.
ESC Heart Failure|January 7, 2021
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fractionYing-Hsiang Lee, Po-Lin Lin, Wei-Ru Chiou, et al.
Journal of the Chinese Medical Association : JCMA|September 15, 2021
Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF studyWen-Yu Lin, Fa-Po Chung, Chia-Te Liao, et al.
Pageof 13